Trials / Completed
CompletedNCT00545883
Impact of GERD on Daily Life (NIS)
An Epidemiological, Observational Study to Describe Symptom Control and Impact on Daily Life of GERD in Patients With Erosive Gastroesophageal Reflux Disease.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,001 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to gather epidemiological data in a population of GERD patients in primary care with a history of erosive esophagitis (less than or equal to 3 years).
Conditions
Timeline
- Start date
- 2006-06-01
- Completion
- 2008-03-01
- First posted
- 2007-10-17
- Last updated
- 2012-01-26
Locations
112 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00545883. Inclusion in this directory is not an endorsement.